@JDB_trading Per toeval een grafiekje voor $SHOP in 1 of andere schuif liggen? :-) thx!
Nederlands
Ward Kennes
4.1K posts
Ward Kennes
@wardkennes
Webdeveloper at LDL Communication https://t.co/9CPCAI6x9w Laravel - PHP - VueJS -
Antwerp (Belgium) Katılım Mayıs 2009
1.2K Takip Edilen484 Takipçiler
$BABA velen zitten hier tot de nok in! Maar volgens de JDB strategie nog altijd GEEN uitbraak. Pas bij doorbraak EMA20 maand ben ik koper.
JDB@JDB_trading
$BABA 77 voorbeurs, Dat betekent voorlopig nog GEEN bullishe uitbraak volgens de JDB strategie.
Nederlands
Ward Kennes retweetledi
$AFMD 24
Of the 94 patients with available ctDNA data for EGFR clonal architecture analysis, 72 (76.6%) showed EGFR as the dominant clone
aacrjournals.org/clincancerres/…
English
$ARWR After review of hundreds of PR's, here my update on 5 partnership's and remaining milestone payments.
Expect a new partnership for ARODUX4 + next muscle candidate in the next weeks.
Upfront >200 millions?
English
@PhilippeGilbert @FelixPouilly Zwijg gij maar gewoon.. de man die zijn haar blondeerde daags nadat ze .....
Nederlands
I am looking for the best approaches for deploying CraftCMS websites. What tools do you guys use? How to keep assets and database in sync?
I already checked this: nystudio107.com/blog/executing…
There must be other ways?
How do you handle sync (prod/dev/staging)?
#craftcms #craft
English
$NVDA Finally monthly supplyzone has been hit. Now watching how prices will react....
English
@tijd Klein foutje in de podcast van vandaag?
"Het is 'woensdag' 10/01"?
Nederlands
nog eens zot gedaan vandaag en deze exact domein match gekocht waar er bijna 15K searches/mnd op zitten in de topmaanden. Verbaasd dat die nog vrij waren.
Volume voor phrase match gaat boven de 70K/mnd. Harde competitie is er niet... gaan we toch iets mee doen :)
Nederlands
$ARWR Remember Morgan Stanley report-my words ?
-We don't see reasons for interim results AHA (APOC3/ANG3)?
-Cash for CVD trials?
-pay model/docs not ready for paradigm shift
ARWR answers:
-Slide 1 speeding ph3 starts winning 1-2Q
-Royalty deal
-Slide 2 NOV/AMGN market opener
BikeRieder🇨🇭@BikeRieder
NOV with Leqvio launch (Inclisiran), is doing some hard work for AMGN and $ARWR and their candidates OLPASIRAN, APOC3 and ANG3. e.g. Free trial offer at start! THX! Launch for ARWR will be much easier and faster. FCS patients have no option but ARWR. NOV with 4 year data at AHA!
English
We just bought a wonderful house.
This is the view from there❤️
English
Ward Kennes retweetledi
BREAKING NEWS! - Just posted $ARWR $AMGN Olpasiran phase 3 cardiovascular outcome study treating Lp(a) now posted. Start 12/21/22 with completion of Dec. 2026! 6,000 participants. Only 4 years - that's a HUGE win. Ph2 data must be spectacular. #RNAi
clinicaltrials.gov/ct2/show/NCT05…
English
@PRAVEENKMRT @harshitbudhraja @Bitbucket @BitbucketStatus No it's not. Click on login... and you get also the 502.
English
English
English
Ward Kennes retweetledi
Today, we are hosting a webcast and conference call at 4:30 p.m. ET to discuss our fiscal 2022 third quarter results. More details here: bit.ly/3BItEDA $ARWR
English
Ward Kennes retweetledi
$AFMD I found Affimed financials very solid. Increased expenses (R&D and G&A) are mostly related to new trials (both wholly owned and partnered assets) and new hirings and consultings. Co. is now well positioned with newly accounted biobucks and a few ATM tap. Now it’s data time!
English
Ward Kennes retweetledi
Our collaborator @JanssenGlobal, presented clinical data from REEF-1, a Phase 2b study of different combination regimens, including JNJ-3989 (formerly ARO-HBV) for the treatment of chronic #HBV infection. Learn more here: bit.ly/30vJLnG $ARWR
English